Block & Leviton Seeks Enovix Investors After 37% Two-Day Drop
Key Highlights
- ➤Enovix (ENVX) disclosed AI-1 cells missed their smartphone energy-density target
- ➤Enovix halted smartphone field testing and shifted development toward smart eyewear
- ➤Enovix announced restructuring cutting 220 positions
- ➤Enovix shares fell approximately 9% after the November 12 disclosure
Boston, Massachusetts--(Newsfile Corp. - November 16, 2026) - Block & Leviton is investigating Enovix (NASDAQ: ENVX) for potential securities law violations. Investors who have lost money in their Enovix investment should contact the firm to learn more about how they might recover those losses. For more details, visit https://blockleviton.com/cases/envx.
Block & Leviton is investigating whether Enovix and certain of its executives misled investors about how close its AI-1 silicon-anode battery cells were to qualifying for use in smartphones. During 2026, management described smartphone qualification as nearly complete. In February, then-CEO Raj Talluri said customer samples had met energy-density requirements, and in August management said only one final accelerated cycle-life test remained. On November 12, 2026, alongside its third-quarter results, Enovix disclosed that its AI-1 cells had missed their energy-density target, that it would not proceed with smartphone field testing, and that it was shifting development toward smart eyewear; it also announced a restructuring cutting 220 positions. On this news, Enovix's stock fell approximately 9%.
Get started
Create a free account to read the full story.
